Literature DB >> 22223867

Malignant pleural mesothelioma.

David S Ettinger1, Wallace Akerley, Hossein Borghaei, Andrew Chang, Richard T Cheney, Lucian R Chirieac, Thomas A D'Amico, Todd L Demmy, Apar Kishor P Ganti, Ramaswamy Govindan, Frederic W Grannis, Leora Horn, Thierry M Jahan, Mohammad Jahanzeb, Anne Kessinger, Ritsuko Komaki, Feng-Ming Spring Kong, Mark G Kris, Lee M Krug, Inga T Lennes, Billy W Loo, Renato Martins, Janis O'Malley, Raymond U Osarogiagbon, Gregory A Otterson, Jyoti D Patel, Mary Pinder Schenck, Katherine M Pisters, Karen Reckamp, Gregory J Riely, Eric Rohren, Scott J Swanson, Douglas E Wood, Stephen C Yang.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22223867     DOI： 10.6004/jnccn.2012.0006

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  18 in total

1.  Clinical practice guidelines for malignant pleural mesothelioma.

Authors:  Nico van Zandwijk
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

Review 2.  Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.

Authors:  Nico van Zandwijk; Christopher Clarke; Douglas Henderson; A William Musk; Kwun Fong; Anna Nowak; Robert Loneragan; Brian McCaughan; Michael Boyer; Malcolm Feigen; David Currow; Penelope Schofield; Beth Ivimey Nick Pavlakis; Jocelyn McLean; Henry Marshall; Steven Leong; Victoria Keena; Andrew Penman
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

3.  Impact of Age on Long-Term Outcomes of Surgery for Malignant Pleural Mesothelioma.

Authors:  Chi-Fu Jeffrey Yang; Brandon W Yan; Robert Ryan Meyerhoff; Shakir M Saud; Brian C Gulack; Paul J Speicher; Matthew G Hartwig; Thomas A D'Amico; David H Harpole; Mark F Berry
Journal:  Clin Lung Cancer       Date:  2016-03-17       Impact factor: 4.785

Review 4.  Management of malignant pleural mesothelioma-The European experience.

Authors:  Isabelle Opitz
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895

Review 5.  Proton beam therapy for malignant pleural mesothelioma.

Authors:  Shahed N Badiyan; Jason K Molitoris; Mingyao Zhu; Erica Glass; Tejan Diwanji; Charles B Simone
Journal:  Transl Lung Cancer Res       Date:  2018-04

6.  Intensity-Modulated Radiation Therapy Improves the Target Coverage Over 3-D Planning While Meeting Lung Tolerance Doses for All Patients With Malignant Pleural Mesothelioma.

Authors:  Sukran Ulger; Eren Cetin; Serap Catli; Hilal Sarac; Diclehan Kilic; Huseyin Bora
Journal:  Technol Cancer Res Treat       Date:  2016-11-15

7.  Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database.

Authors:  Robert Ryan Meyerhoff; Chi-Fu Jeffrey Yang; Paul J Speicher; Brian C Gulack; Matthew G Hartwig; Thomas A D'Amico; David H Harpole; Mark F Berry
Journal:  J Surg Res       Date:  2015-01-29       Impact factor: 2.192

Review 8.  New insights into understanding the mechanisms, pathogenesis, and management of malignant mesotheliomas.

Authors:  Brooke T Mossman; Arti Shukla; Nicholas H Heintz; Claire F Verschraegen; Anish Thomas; Raffit Hassan
Journal:  Am J Pathol       Date:  2013-02-08       Impact factor: 4.307

9.  Tsc1-Tp53 loss induces mesothelioma in mice, and evidence for this mechanism in human mesothelioma.

Authors:  Y Guo; L R Chirieac; R Bueno; H Pass; W Wu; I A Malinowska; D J Kwiatkowski
Journal:  Oncogene       Date:  2013-07-15       Impact factor: 9.867

Review 10.  Extrapleural pneumonectomy or pleurectomy/decortication for malignant pleural mesothelioma.

Authors:  Seiki Hasegawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.